Device / Technology News

RSS

Research involves new, safer ways to deliver biomedical agents against tumors

Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.

16 Feb 2013

Spherical nucleic acids could revolutionize biomedicine

Northwestern University's Chad A. Mirkin, a world-renowned leader in nanotechnology research and its application, has invented and developed a powerful material that could revolutionize biomedicine: spherical nucleic acids (SNAs).

16 Feb 2013

New confirmatory diagnostic test highly accurate in distinguishing mothers with preeclampsia

Carmenta Bioscience, Inc., in collaboration with researchers at Stanford University, today announced presentation of results from a retrospective clinical study at the 2013 Society of Maternal Fetal Medicine national meeting.

16 Feb 2013

Canine Pompe disease can now be diagnosed with genetic test

Pompe disease, a severe glycogen storage disease appearing in Lapphunds is caused by a genetic defect in acid α-glucosidase gene. The same genetic mutation also causes the equivalent disease in humans. Based on this finding, canine Pompe disease can now be diagnosed with a genetic test.

16 Feb 2013

Research roundup: Conflict of interest in Medicaid drug purchasing; Examining Medigap policies; Electronic medical records and hospital quality

The authors of this study assert that the decisions about which drugs are selected for state Medicaid reimbursement programs "should be based on available evidence and free of conflicts of interests (COIs)."

15 Feb 2013

Examining electronic medical records and over-billing

The Obama administration is forging ahead with a multi-billion dollar plan to shift from paper to electronic medical records, despite continuing concerns the program may be prompting some doctors and hospitals to improperly bill higher fees to Medicare.

15 Feb 2013

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

15 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

University of York develops new medical tool that could help surgeons during complex procedures

Scientists at the University of York have developed a new medical tool which could help surgeons carrying out complex procedures in the operating theatre.

15 Feb 2013

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.

15 Feb 2013

ReCor Medical initiates PARADISE system post-market study in high blood pressure

ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a minimally invasive 6Fr Over-The-Wire (OTW) ultrasound device for treating resistant high blood pressure.

15 Feb 2013

Castle Biosciences launches MyUvealMelanoma website

Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.

15 Feb 2013

SPI Pharma launches Actimask Ibuprofen 92S

SPI Pharma, Inc., a global leader in providing pharmaceutical ingredients and technologies for patient-friendly dosage forms, announces the launch of Actimask Ibuprofen 92S, a taste-masked Ibuprofen.

15 Feb 2013

Ingenuity Systems receives HIPAA Certification

Ingenuity Systems, a leading provider of biomedical information and analysis solutions, today announced that it has passed the Health Insurance Portability and Accountability Act (HIPAA) audit, confirming that Ingenuity's data center and Ingenuity Variant Analysis are in compliance with relevant Federal Regulations.

15 Feb 2013

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Gamida Cell announced today the successful results of the Phase I/II study of its second pipeline product NiCord, umbilical cord derived stem cells expanded using the company's proprietary NAM technology.

15 Feb 2013

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

QPID Inc. launched today, delivering a new health record intelligence platform and web-based applications that enable health care institutions and clinicians to gain better insights from any Electronic Health Record (EHR).

15 Feb 2013

Personalis announces availability of Genome Services for Research

Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.

14 Feb 2013

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

14 Feb 2013

L-COR Biosciences launches C-DiGit Blot Scanner

Today, LI-COR Biosciences continues to demonstrate its position as a leader in laboratory instrument systems as it announces the launch of the C-DiGit Blot Scanner.

14 Feb 2013

Study finds strong preference among families and older pediatric patients for IV feeding

About 60 percent of pediatric cancer patients experience malnourishment during treatment. At that point, patients and families have a choice: tube feeding or IV nutrition supplement. Which would you choose? A study published this week in the Journal of Pediatric Oncology Nursing shows that families' perceptions, especially of the discomfort of tube feeding, leads to choosing IV over tube - despite the fact that tube feeding is usually the better choice, associated with better gut function and lower rates of infection.

14 Feb 2013

Device / Technology News

Research involves new, safer ways to deliver biomedical agents against tumors

Spherical nucleic acids could revolutionize biomedicine

New confirmatory diagnostic test highly accurate in distinguishing mothers with preeclampsia

Canine Pompe disease can now be diagnosed with genetic test

Research roundup: Conflict of interest in Medicaid drug purchasing; Examining Medigap policies; Electronic medical records and hospital quality

Examining electronic medical records and over-billing

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

University of York develops new medical tool that could help surgeons during complex procedures

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

ReCor Medical initiates PARADISE system post-market study in high blood pressure

Castle Biosciences launches MyUvealMelanoma website

SPI Pharma launches Actimask Ibuprofen 92S

Ingenuity Systems receives HIPAA Certification

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

Personalis announces availability of Genome Services for Research

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

L-COR Biosciences launches C-DiGit Blot Scanner

Study finds strong preference among families and older pediatric patients for IV feeding

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News